CEBPZ and acute myeloid leukemia: GO is also approved in the US to be used in combination with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) [10], and as standard treatment for core-binding factor positive AML (CBF-AML) [10, 11].